Risk analysis is not yet available for this country's tenders. Currently supported: Estonia, Latvia, Lithuania, Poland, France, UK, Denmark, Netherlands, Norway, and Finland.
Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.
LoginUpgrade to see which companies are likely to bid on this tender, based on historical procurement data.
LoginAI extracts and organizes all requirements from tender documents — mandatory qualifications, technical specifications, financial conditions, and submission rules — clearly categorized so you know exactly what's needed to bid.
Login3 documents available with AI summaries
This OCDS record announces an intention to directly award a contract for referred molecular tests to an existing supplier under the Provider Selection Regime, inviting representations from other providers by February 6, 2026.
This OCDS notice details Integrated Laboratory Solutions LLP's intention to directly award a call-off contract for referred molecular tests to an existing supplier under the Provider Selection Regime, with a standstill period for representations.
This document is an intent to award notice for a direct call-off contract for referred molecular tests, indicating the contracting authority's plan to award the contract to an existing supplier.
Sign up to view document summaries and analysis
Comprehensive quality analysis of this tender scoring legal compliance, clarity, completeness, fairness, practicality, data consistency, and sustainability on a 0-100 scale with detailed breakdown and recommendations.
LoginHello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required